日本ケミファ(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|---|---|---|
| 東証STD | 医薬品 | 4539/E00957 | NIPPON CHEMIPHAR CO., LTD. |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|---|---|---|---|---|---|---|---|---|
| 2025/04/18 | 日証協 | 156,277株 | 0% | 0株 | 0.00% | 79,683株 | -0.5% | 0株 | 0.00% |
| 2025/04/11 | 日証協 | 156,277株 | -0.64% | 100株 | -99.89% | 80,083株 | -1.84% | 700株 | -95.62% |
| 2025/04/04 | 日証協 | 157,277株 | +104.84% | 94,608株 | +67.14% | 81,583株 | +64.54% | 16,000株 | -69.75% |
| 2025/03/28 | 日証協 | 76,780株 | +167.41% | 56,604株 | +708.17% | 49,581株 | -3.12% | 52,888株 | +9999.99% |
| 2025/03/21 | 日証協 | 28,712株 | +0.7% | 7,004株 | -47.76% | 51,179株 | +0.2% | 450株 | +50% |
| 2025/03/14 | 日証協 | 28,512株 | -1.72% | 13,408株 | +112.69% | 51,079株 | +2.2% | 300株 | -76.92% |
| 2025/03/07 | 日証協 | 29,012株 | 0% | 6,304株 | +3052% | 49,979株 | -4.22% | 1,300株 | +331.89% |
| 2025/02/28 | 日証協 | 29,012株 | -2.03% | 200株 | -97.1% | 52,179株 | -2.61% | 301株 | -57% |
| 2025/02/21 | 日証協 | 29,612株 | +0.2% | 6,904株 | 0% | 53,578株 | +0.11% | 700株 | +40% |
| 2025/02/14 | 日証協 | 29,553株 | +0.68% | 0株 | -100% | 53,519株 | +0.57% | 500株 | -72.28% |
| 2025/02/07 | 日証協 | 29,353株 | -4.24% | 14,104株 | +78.92% | 53,218株 | -1.95% | 1,804株 | -74.38% |
| 2025/01/31 | 日証協 | 30,653株 | +6.92% | 7,883株 | -22.75% | 54,275株 | +4.43% | 7,041株 | +290.95% |
| 2025/01/24 | 日証協 | 28,670株 | -13.76% | 10,204株 | -56.41% | 51,975株 | -5.76% | 1,801株 | -81.99% |
| 2025/01/17 | 日証協 | 33,246株 | +9.2% | 23,407株 | +114.64% | 55,153株 | -1.61% | 10,000株 | +564.45% |
| 2025/01/10 | 日証協 | 30,446株 | -6.81% | 10,905株 | +2081% | 56,054株 | -3.82% | 1,505株 | +114.69% |
| 2024/12/30 | 日証協 | 32,670株 | +0.31% | 500株 | -97.11% | 58,279株 | -0.17% | 701株 | -79.42% |
| 2024/12/27 | 日証協 | 32,570株 | +0.98% | 17,308株 | +113.57% | 58,379株 | +0.87% | 3,406株 | +183.13% |
| 2024/12/20 | 日証協 | 32,253株 | +0.94% | 8,104株 | -1.22% | 57,873株 | -0.17% | 1,203株 | +6.46% |
| 2024/12/13 | 日証協 | 31,953株 | +0.56% | 8,204株 | +7.89% | 57,970株 | -1.31% | 1,130株 | +438.1% |
※株式分割は考慮していませんのでご注意ください。